- Home
- MEDP vs WAL Comparison
MEDP vs WAL Comparison
Compare MEDP & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- WAL
- Stock Information
- Founded
- MEDP 1992
- WAL 1994
- Country
- MEDP United States
- WAL United States
- Employees
- MEDP N/A
- WAL N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- WAL Major Banks
- Sector
- MEDP Health Care
- WAL Finance
- Exchange
- MEDP Nasdaq
- WAL Nasdaq
- Market Cap
- MEDP 10.5B
- WAL 9.3B
- IPO Year
- MEDP 2016
- WAL 2005
- Fundamental
- Price
- MEDP $312.74
- WAL $76.11
- Analyst Decision
- MEDP Buy
- WAL Strong Buy
- Analyst Count
- MEDP 10
- WAL 15
- Target Price
- MEDP $373.22
- WAL $98.07
- AVG Volume (30 Days)
- MEDP 384.3K
- WAL 1.1M
- Earning Date
- MEDP 04-21-2025
- WAL 04-17-2025
- Dividend Yield
- MEDP N/A
- WAL 2.00%
- EPS Growth
- MEDP 42.23
- WAL 8.41
- EPS
- MEDP 12.63
- WAL 7.09
- Revenue
- MEDP $2,109,054,000.00
- WAL $3,016,200,000.00
- Revenue This Year
- MEDP $4.64
- WAL $13.49
- Revenue Next Year
- MEDP $9.74
- WAL $10.02
- P/E Ratio
- MEDP $24.73
- WAL $10.74
- Revenue Growth
- MEDP 11.84
- WAL 17.96
- 52 Week Low
- MEDP $302.01
- WAL $53.75
- 52 Week High
- MEDP $459.77
- WAL $98.10
- Technical
- Relative Strength Index (RSI)
- MEDP 40.74
- WAL 40.46
- Support Level
- MEDP $314.00
- WAL $75.24
- Resistance Level
- MEDP $331.24
- WAL $81.94
- Average True Range (ATR)
- MEDP 8.84
- WAL 2.48
- MACD
- MEDP -0.39
- WAL 0.46
- Stochastic Oscillator
- MEDP 18.32
- WAL 43.73
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.